Dorzolamide hydrochloride is a carbonic anhydrase inhibitor used in the treatment of glaucoma and ocular hypertension to reduce the production of aqueous humor. As a potent topical ophthalmic agent, its… Read more
![Chemical structure of (4R,6R)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R6R-4-Ethylamino-6-methyl-56-dihydro-4H-thieno23-bthiopyran-2-sulfonamide-77-dioxide.png&w=3840&q=75)
![Chemical structure of (4R,6R)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide Maleate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F199734-60-6-4R6R-4-Ethylamino-6-methyl-56-dihydro-4H-thieno23-bthiopyran-2-sulfonamide-77-dioxide-Maleate.png&w=3840&q=75)
![Chemical structure of (4R,6S)-4-((2-Methoxyethoxy)methoxy)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R6S-4-2-Methoxyethoxymethoxy-6-methyl-56-dihydro-4H-thieno23-bthiopyran.png&w=3840&q=75)
Dorzolamide hydrochloride is a carbonic anhydrase inhibitor used in the treatment of glaucoma and ocular hypertension to reduce the production of aqueous humor. As a potent topical ophthalmic agent, its quality and consistency are critical, requiring rigorous analytical oversight during development and manufacturing. This category provides essential reference standards, including the active pharmaceutical ingredient, relevant pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are fundamental to pharmaceutical laboratories for impurity profiling, method validation, and routine quality control testing. By utilizing these high-quality reference standards, analysts can accurately identify and quantify related substances, ensuring compliance with strict regulatory requirements for ophthalmic formulations. Access to these characterized materials supports the development of robust analytical methods necessary to maintain the safety and efficacy of therapeutic products containing this compound.